Elevance Health, Inc.
ELV
$285.03
$3.311.17%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 41.76B | 41.48B | 36.77B | 37.36B | 35.92B |
| Total Other Revenue | 8.02B | 7.41B | 8.67B | 7.79B | 7.72B |
| Total Revenue | 49.78B | 48.89B | 45.44B | 45.15B | 43.65B |
| Cost of Revenue | 36.71B | 35.31B | 33.50B | 32.95B | 30.57B |
| Gross Profit | 13.07B | 13.58B | 11.94B | 12.20B | 13.07B |
| SG&A Expenses | 10.29B | 10.28B | 10.78B | 10.09B | 9.89B |
| Depreciation & Amortization | 147.00M | 155.00M | 180.00M | 122.00M | 162.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.14B | 45.75B | 44.46B | 43.17B | 40.62B |
| Operating Income | 2.63B | 3.14B | 987.00M | 1.98B | 3.03B |
| Income Before Tax | 2.29B | 2.80B | 606.00M | 1.37B | 2.99B |
| Income Tax Expenses | 548.00M | 613.00M | 193.00M | 365.00M | 685.00M |
| Earnings from Continuing Operations | 1.74B | 2.18B | 413.00M | 1.01B | 2.30B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.00M | -1.00M | 5.00M | 8.00M | -1.00M |
| Net Income | 1.74B | 2.18B | 418.00M | 1.02B | 2.30B |
| EBIT | 2.63B | 3.14B | 987.00M | 1.98B | 3.03B |
| EBITDA | 3.01B | 3.51B | 1.39B | 2.31B | 3.36B |
| EPS Basic | 7.74 | 9.64 | 1.81 | 4.38 | 9.91 |
| Normalized Basic EPS | 6.36 | 7.72 | 1.77 | 4.56 | 7.39 |
| EPS Diluted | 7.72 | 9.61 | 1.81 | 4.36 | 9.85 |
| Normalized Diluted EPS | 6.34 | 7.69 | 1.77 | 4.54 | 7.35 |
| Average Basic Shares Outstanding | 225.20M | 226.40M | 231.10M | 231.90M | 232.20M |
| Average Diluted Shares Outstanding | 225.80M | 227.20M | 231.10M | 233.10M | 233.40M |
| Dividend Per Share | 1.71 | 1.71 | 1.63 | 1.63 | 1.63 |
| Payout Ratio | 22.09% | 17.68% | 89.23% | 37.20% | 16.43% |